Manganese porphyrin reduces renal injury and mitochondrial damage during ischemia/reperfusion.
about
Mitochondria-Targeted Antioxidants: Future Perspectives in Kidney Ischemia Reperfusion InjuryMn porphyrin-based SOD mimic, MnTnHex-2-PyP(5+), and non-SOD mimic, MnTBAP(3-), suppressed rat spinal cord ischemia/reperfusion injury via NF-κB pathwaysAlteration of renal respiratory Complex-III during experimental type-1 diabetesRole of reduced manganese superoxide dismutase in ischemia-reperfusion injury: a possible trigger for autophagy and mitochondrial biogenesis?CNS bioavailability and radiation protection of normal hippocampal neurogenesis by a lipophilic Mn porphyrin-based superoxide dismutase mimic, MnTnBuOE-2-PyP5.Compensatory proteome adjustments imply tissue-specific structural and metabolic reorganization following episodic hypoxia or anoxia in the epaulette shark (Hemiscyllium ocellatum).Neuroprotective efficacy from a lipophilic redox-modulating Mn(III) N-Hexylpyridylporphyrin, MnTnHex-2-PyP: rodent models of ischemic stroke and subarachnoid hemorrhageSuperoxide dismutase mimics: chemistry, pharmacology, and therapeutic potentialPotential therapeutic benefits of strategies directed to mitochondria.Time dependent bladder apoptosis induced by acute bladder outlet obstruction and subsequent emptying is associated with decreased MnSOD expression and Bcl-2/Bax ratioDesign of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities.Novel resveratrol analogues attenuate renal ischemic injury in rats.Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury.Effect of lipophilicity of Mn (III) ortho N-alkylpyridyl- and diortho N, N'-diethylimidazolylporphyrins in two in-vitro models of oxygen and glucose deprivation-induced neuronal death.Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimicsRole of mitochondrial oxidants in an in vitro model of sepsis-induced renal injury.Spinal mitochondrial-derived peroxynitrite enhances neuroimmune activation during morphine hyperalgesia and antinociceptive tolerance.Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotectionPharmacokinetics of the potent redox-modulating manganese porphyrin, MnTE-2-PyP(5+), in plasma and major organs of B6C3F1 miceChanging the energy of an immune responseImpact of electrostatics in redox modulation of oxidative stress by Mn porphyrins: protection of SOD-deficient Escherichia coli via alternative mechanism where Mn porphyrin acts as a Mn carrier.ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells.MnTMPyP, a cell-permeant SOD mimetic, reduces oxidative stress and apoptosis following renal ischemia-reperfusion.Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking the development of morphine antinociceptive tolerance through peroxynitrite-mediated pathways.Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+.Reactive oxygen species mediate liver injury through parenchymal nuclear factor-kappaB inactivation in prolonged ischemia/reperfusion.Lipophilicity of potent porphyrin-based antioxidants: comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins.Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP(5+), via suppression of oxidative stress in a mouse model of breast tumorManganese provides antioxidant protection for sperm cryopreservation that may offer new consideration for clinical fertilityProtective effect of metalloporphyrins against cisplatin-induced kidney injury in mice.The use of the Cre/loxP system to study oxidative stress in tissue-specific manganese superoxide dismutase knockout models.Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+).Mitochondrial metals as a potential therapeutic target in neurodegeneration.Manganese superoxide dismutase, MnSOD and its mimicsProteomic approaches in understanding action mechanisms of metal-based anticancer drugs.Design and synthesis of manganese porphyrins with tailored lipophilicity: investigation of redox properties and superoxide dismutase activityRadioprotective effects of manganese-containing superoxide dismutase mimics on ataxia-telangiectasia cells.Sirtuin 1 Stimulation Attenuates Ischemic Liver Injury and Enhances Mitochondrial Recovery and AutophagyLate administration of Mn porphyrin-based SOD mimic enhances diabetic complications.High lipophilicity of meta Mn(III) N-alkylpyridylporphyrin-based superoxide dismutase mimics compensates for their lower antioxidant potency and makes them as effective as ortho analogues in protecting superoxide dismutase-deficient Escherichia coli
P2860
Q26744639-1D4939E2-D2C5-4540-8438-AD66F0EE7F0BQ28389277-AD293448-4F1C-407E-BD62-9E60CAE6D0E2Q28569836-01A6A4FE-06D0-4768-8461-5C1CB5B268EAQ28595011-0D0DC8EF-99F7-4744-815C-B7B40C4B6A69Q33610242-FDD2EDAC-C59D-4103-A657-FBC60581650EQ33924866-B5BD834C-7444-4076-82C8-D4AEC5920395Q33926426-C701DA0A-CDF8-4CC5-93CA-EDC09ADABEC7Q34110107-ED3E94DB-7248-4E11-91DD-6C0C1AF34870Q34117168-58F88DF6-B29C-4512-AE1B-910EFD50E9CDQ34255655-8AC69059-E36D-4629-AC9A-99381CA8BE46Q34500616-2F15B556-0204-42D3-908C-005E33541371Q34716242-BA2C2814-FEE3-4E12-AC62-E3950870B9E6Q34854255-93B330A9-2C9D-4FAA-85A9-EC8B6EABFBA5Q35177269-F6D4A604-48AD-4C1D-93C7-1930CD4B85F5Q35228718-45B22877-4A08-49D3-9AB3-D18F9B458CD3Q35650706-E3BD913A-DBFA-4CCC-869E-7EB088E7C780Q36920496-872A4746-E98E-4B04-AC32-A4B4B18E653CQ36933231-1CF82CD3-A513-42A7-9626-F15FF804B37EQ36973998-C81D6A6C-036B-43E6-A448-9E95077CAE93Q37021691-2ADA9401-45E0-4455-9272-7C28883161D2Q37038133-E83C9B5F-47C8-4001-9D3C-E0CD2A35889DQ37072265-F1F9F5CE-F7D8-4386-9BD8-7A7DD764F7B3Q37100054-B76E3861-2A29-4D03-8D28-61B154B439D7Q37131042-B63EC0F6-7F3E-4092-8472-91EE556ED53BQ37148919-F96C167F-27DD-43E0-ADFA-30C1DA59CF5CQ37164211-7BBBB3C8-2D50-4256-B50F-1294FE3C5304Q37222820-D6597D7B-2A09-4273-A917-5F750AF2CD67Q37358536-5419CDF8-7FEA-4CE5-AACF-8CAE529FE73BQ37390276-BEE5964C-5C4D-494F-9951-CA78916F32FFQ37479069-28619228-5770-4CDD-917E-32BAC3091E63Q37617637-7C846219-818D-44FE-81FF-100BB2EA13EEQ37629336-2C552A43-B9B9-4EA2-8E83-CCE5208D68D2Q37686294-FFEA1D28-D2F5-497D-90B3-BFEEDEDFC8B5Q37971277-3BBB0F09-AFC9-4E9B-B9D1-9548DFE8A719Q40064331-2493F10F-5A11-4F81-8EB6-5525B8D78565Q41327195-BDDF9B11-C452-4BC5-AACC-77512F0100E4Q41422364-D19E8CCE-67B0-4DB4-A16B-2E17D5503893Q41791002-8FF94CA4-1BF4-4105-B31A-53318B99B9D5Q41876611-305454E2-7F52-4D87-B729-18CE6A4B4BDAQ42045220-62940966-AB86-4B32-B2D5-0F60A2140993
P2860
Manganese porphyrin reduces renal injury and mitochondrial damage during ischemia/reperfusion.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Manganese porphyrin reduces re ...... e during ischemia/reperfusion.
@ast
Manganese porphyrin reduces re ...... e during ischemia/reperfusion.
@en
type
label
Manganese porphyrin reduces re ...... e during ischemia/reperfusion.
@ast
Manganese porphyrin reduces re ...... e during ischemia/reperfusion.
@en
prefLabel
Manganese porphyrin reduces re ...... e during ischemia/reperfusion.
@ast
Manganese porphyrin reduces re ...... e during ischemia/reperfusion.
@en
P2093
P2860
P1476
Manganese porphyrin reduces re ...... ge during ischemia/reperfusion
@en
P2093
Hamida Saba
Ines Batinic-Haberle
Judit Megyesi
Lee Ann MacMillan-Crow
Tanecia Mitchell
P2860
P304
P356
10.1016/J.FREERADBIOMED.2007.02.016
P577
2007-02-28T00:00:00Z